Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research

• Through the CAT1D, expand the cohort construction of type 1 diabetes patients and first-level relatives in China, establish the electronic information database of type 1 diabetes, and lay a foundation for obtaining the research data of type 1 diabetes in China.
• observe and study the occurrence and development rules of acute and chronic complications of type 1 diabetes in China, analyze the influencing factors, and provide intervention means for reducing acute complications and preventing chronic complications.
• Through the established management platform and structured education system, verify and promote the comprehensive management mode based on structured education, and build a standard treatment plan and process based on evidence-based science and suitable for Chinese people and medical background.
• By using mobile health (mHealth) and Artificial Intelligence (AI) technologies, a new mode of intelligent structured education is established, which provides a new way to explore the individualized education management mode and improve the outcome of chronic diseases through modern technology.

Inclusion criteria

• Individuals diagnosed with Type 1 Diabetes according to the 1999 World Health Organization report
• Written informed consent from the patient or family representative;
• Individuals who own smartphone and are capable of using wechat or apps

Exclusion criteria

• Non-t1dm patients with autoimmune polyendocrine adenopathy syndrome (APS) are the first disease
• With mental disorders
• Have any other condition or disease that may hamper from compliance with the protocol or complication of the trial